Triple negative breast cancer cell lines: One tool in the search for better treatment of triple negative breast cancer

Issue title: Triple Negative Breast Cancer: Breast Cancer Research in Evolution

Guest editors: Jennifer Eng-Wongx and Jo Anne Zujewskiy

Article type: Research Article

Authors: Chavez, Kathryn J.^{; 1} | Garimella, Sireesha V.^{; 1} | Lipkowitz, Stanley^{; *}

Affiliations: Laboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA | [x] Lombardi Comprehensive Cancer Center, Georgetown University, Washington DC, USA | [y] Clinical Trial Evaluation Program (CTEP), National Cancer Institute, Bethesda MD, USA

Correspondence: [*] Address correspondence: Stanley Lipkowitz, MD, PhD, LCMB, CCR, NCI, Room 2066, 37 Convent Dr., Bethesda, MD 20892, USA. E-mail: lipkowis@mail.nih.gov

Note: [1] These authors contributed equally to this work.

DOI: 10.3233/BD-2010-0307

Journal: Breast Disease, vol. 32, no. 1-2, pp. 35-48, 2011